NCT00159536

Metformin in Pregnant PCOS Women

Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome (PCOS)

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 257 (actual)
• Sponsor: Norwegian University of Science and Technology · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

To investigate the effect of metformin on pregnancy complications and pregnancy outcome in the II. and III. trimester of pregnancy in women with polycystic ovary syndrome.

Conditions

• Polycystic Ovary Syndrome

Interventions

Type	Name	Description
DRUG	Metformin	Metformin 1000 mg x 2 per day. Orally. From inclusion (before gestational week 12) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study
DRUG	Placebo	Placebo, 2 tablets x 2 daily.Orally. From inclusion (that is before gestational week 12) to delivery. Verbal and written diet and lifestyle advices at inclusion to the study

Timeline

• Start date: 2005-02-01
• Primary completion: 2009-10-01
• Completion: 2009-10-01
• First posted: 2005-09-12
• Last updated: 2019-02-15

Locations

10 sites across 1 country: Norway